Results 351 to 360 of about 424,378 (382)
Some of the next articles are maybe not open access.

Complement Activation and Inhibition in Autoimmune Hemolytic Anemia: Focus on Cold Agglutinin Disease.

Seminars in hematology (Print), 2018
The classical complement pathway and, to some extent, the terminal pathway, are involved in the immune pathogenesis of autoimmune hemolytic anemia (AIHA).
S. Berentsen
semanticscholar   +1 more source

Hemolytic Anemias in Pregnancy

Clinical Obstetrics and Gynecology, 1995
Polymorphism exists and complicates the diagnosis of inherited hemolytic anemias. However, with linkage DNA analysis and, on occasion, with characterization of the mutant gene, it is possible to make a diagnosis on the DNA level. This technique increases our understanding of the enzymatic defect and the relationship with clinical findings.
openaire   +3 more sources

Autoimmune hemolytic anemia

The Indian Journal of Pediatrics, 2008
To study the clinico-hematological profile and treatment outcome in children suffering from auto immune hemolytic anemia (AIHA).Twelve children were diagnosed with auto immune hemolytic anemia over a period of four years. Direct antiglobulin test was positive in all the cases.
B. D. Bhatia   +2 more
openaire   +3 more sources

Hydroxylamines and Hemolytic Anemia [PDF]

open access: possible, 1986
Hemolytic anemia, the uncompensated loss of red blood cells from the circulation, has been recognized as a side effect of drugs and other chemicals for over 50 years (Muelens, 1926; Cordes, 1926). This response is commonly associated with the aminoquinoline drugs, pamaquine and primaquine (Beutler, 1959); indeed the extensive studies carried out with ...
James H. Harrison   +2 more
openaire   +2 more sources

Hemolytic Anemia in the Newborn

Clinics in Perinatology, 1995
Evaluation of hemolytic anemia in the newborn may be complicated owing to the physiologic changes that occur during this time; however, the newborn period is a time when congenital red cell abnormalities may first present and when maternal factors need to be considered.
Bertram H. Lubin   +2 more
openaire   +3 more sources

Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma.

Melanoma research, 2016
We report the occurrence of autoimmune hemolytic anemia in a patient receiving the anti-PD-1 monoclonal antibody, nivolumab, for metastatic melanoma in the presence of known red cell alloantibodies, despite having received prior ipilimumab without ...
B. Kong   +4 more
semanticscholar   +1 more source

Cephalothin and Hemolytic Anemia

Annals of Internal Medicine, 1970
Excerpt To the editor: In the May 1970 issue of the ANNALS, Drs. Weinstein and Kaplan in the article "The Cephalosporins" made the following statement: "Therapy with cephalothin and, much less comm...
openaire   +3 more sources

The Hemolytic Anemias.

Archives of Internal Medicine, 1963
The expression, j'adoube , requires no explanation for a chess player. For the benefit of the pinochle pack, it indicates the intent of a player to adjust the position of one of his pieces on the square already occupied by that piece. Should a player touch his piece without this statement of intent, he must make a definitive move with that piece.
openaire   +2 more sources

Autoimmune Hemolytic Anemia

Archives of Internal Medicine, 1975
Warm-type autoantibodies of autoimmune hemolytic anemia (AIHA) are usually IgG but may be IgM or IgA. They are usual Rh specific. Cold-type antibodies are IgM or IgG (Donath-Landsteiner [DL] antibody). IgM antibodies are usually anit-l (occasionally anti-i) and DL antibodies anti-P.
openaire   +3 more sources

Autoimmune hemolytic anemia

Human Pathology, 1983
Nowhere in the management of patients with autoimmune hemolytic anemias is the communication between clinician and laboratory personnel more important than in regard to blood transfusion. A clinical decision that blood transfusion is necessary must be tempered by the knowledge that transfusion has a greater-than-usual risk in this setting, both because
openaire   +3 more sources

Home - About - Disclaimer - Privacy